VP, Research and Development Strategy @ MindMed (November 2024 - May 2025)
Associate Director for Therapeutic Review @ (September 2018 - September 2024)
Supervisory General Health Scientist for Controlled Substances Initiatives (acting). @ (August 2023 - December 2023)
Deputy Director (Acting), Division of Pychiatry Products @ (January 2019 - October 2019)
Clinical Team Leader. Division of Psychiatry Products. Office of New Drugs. FDA @ (April 2016 - September 2018)
Clinical Reviewer. Division of Psychiatry Products, CDER and Office of New Drugs @ (December 2015 - April 2016)
Clinical Review Officer, Division of Analgesia, Anesthesia, and Addiction Products @ (March 2014 - December 2015)
Medical Officer @ (December 2008 - September 2024)
Javier A. Muniz Education
Icahn School of Medicine at Mount Sinai
Psychiatry Residency Program
2002-2004
Jefferson Health
Psychiatry Residency Program
2000-2002
Universidad Central del Caribe
Doctor of Medicine (MD) (Medicine)
1996-2000
Universidad de Puerto Rico 1992-1996
Javier A. Muniz Skills
Psychiatry
Military Psychiatry
Psychopharmacology
Drug Development
Pharmacology
Neuroscience
Disaster Response
Addiction Psychiatry
Sleep Disorders
Pain Management
Post Traumatic Stress
Biosurety
Security Clearance
Mental Health
Clinical Research
Healthcare
Medicine
Medical Education
Public Speaking
Board Certified
Clinical Trials
Healthcare Management
Javier A. Muniz Summary
Javier A. Muniz, based in Silver Spring, MD, US, is currently a Chief Medical Officer at Lykos Therapeutics. Javier A. Muniz brings experience from previous roles at Muniz PsyNova Solutions LLC, MindMed and FDA. Javier A. Muniz holds a 2002 - 2004 Psychiatry Residency Program @ Icahn School of Medicine at Mount Sinai. With a robust skill set that includes Psychiatry, Military Psychiatry, Psychopharmacology, Drug Development, Pharmacology and more. Javier A. Muniz has 2 emails and 9 mobile phone numbers on RocketReach.
Looking for a different Javier A. Muniz?
Find contact details for 700 million professionals.